Purple Biotech Ltd (TLV:PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
At close: Mar 6, 2026
Purple Biotech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
18.58M ILS
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Can-Fite BioPharma | 1.89M |
| XTL Biopharmaceuticals | 3.26M |
| Evogene | 26.54M |
| BioLight Life Sciences | 21.00K |
| BioLineRx | 42.17M |
| Clal Biotechnology Industries | 91.00K |
| Geffen Residence & Renewal | 84.00K |
Purple Biotech News
- 3 months ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 4 months ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 5 months ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 6 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 6 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Purple Biotech Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 months ago - Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025 - GlobeNewsWire